<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of breakthrough invasive <z:e sem="disease" ids="C0043541" disease_type="Disease or Syndrome" abbrv="">zygomycosis</z:e> in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei <z:e sem="disease" ids="C0085082" disease_type="Disease or Syndrome" abbrv="">fungemia</z:e> that occurred during <z:chebi fb="2" ids="46081">fluconazole</z:chebi> prophylaxis </plain></SENT>
<SENT sid="1" pm="."><plain>Also, patients receiving the echinocandin caspofungin remain at risk for pathogens, such as <z:e sem="disease" ids="C0043541" disease_type="Disease or Syndrome" abbrv="">zygomycetes</z:e>, that are intrinsically resistant to this agent </plain></SENT>
</text></document>